Role of mitofusin 2 mutations in the physiopathology of Charcot–Marie–Tooth disease type 2A
- 8 May 2009
- journal article
- review article
- Published by Elsevier BV in Experimental Neurology
- Vol. 218 (2), 268-273
- https://doi.org/10.1016/j.expneurol.2009.05.003
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- Mitofusin 2 tethers endoplasmic reticulum to mitochondriaNature, 2008
- Mitochondrial Fusion Is Increased by the Nuclear Coactivator PGC-1βPLOS ONE, 2008
- Mitochondrial GTPase mitofusin 2 mutations in Korean patients with Charcot‐Marie‐Tooth neuropathy type 2Clinical Genetics, 2007
- Complementation between mouse Mfn1 and Mfn2 protects mitochondrial fusion defects caused by CMT2A disease mutationsThe Journal of cell biology, 2007
- Dissecting Mitochondrial FusionDevelopmental Cell, 2006
- Axonal transport of mitochondria requires milton to recruit kinesin heavy chain and is light chain independentThe Journal of cell biology, 2006
- The GTPase dMiro Is Required for Axonal Transport of Mitochondria to Drosophila SynapsesNeuron, 2005
- Mitochondrial GTPase mitofusin 2 mutation in Charcot?Marie?Tooth neuropathy type 2AHuman Genetics, 2004
- Nuclear gene OPA1, encoding a mitochondrial dynamin-related protein, is mutated in dominant optic atrophyNature Genetics, 2000
- OPA1, encoding a dynamin-related GTPase, is mutated in autosomal dominant optic atrophy linked to chromosome 3q28Nature Genetics, 2000